Recursion Pharmaceuticals
Tracked across 1 events · 6 articles · First seen Jun 26, 2026 · Last active Jul 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Recursion Pharmaceuticals shares were acquired by ARK Investment Management, suggesting a contrarian bet on the company's growth despite its stock trading significantly below its 52-week high.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Recursion Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard